T7764 |
CCG-222740
|
1922098-69-8
|
98.79%
|
|
CCG-222740 is an inhibitor of Rho/MRTF pathway
|
T9972 |
Divarasib
|
2417987-45-0
|
98.79%
|
|
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM. Divarasib irreversibly ...
|
T5469 |
K-Ras-IN-1
|
84783-01-7
|
98.72%
|
|
K-Ras-IN-1 is a K-Ras inhibitor.
|
T9407 |
Rasarfin
|
674359-73-0
|
98.58%
|
|
Rasarfin inhibits Ras and ARF6.
|
T22258 |
(S)-AMG-510
|
2252403-56-6
|
98.57%
|
|
(S)-AMG-510 is an S-type compound of AMG-510, a potent covalent inhibitor of KRAS G12C with potential antitumor activity.
|
T5379 |
(Rac)-Antineoplaston A10
|
77658-84-5
|
98.47%
|
|
(Rac)-Antineoplaston A10 (Antineoplaston A10) is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It d...
|
T2267 |
BQU57
|
1637739-82-2
|
98.36%
|
|
BQU57 shows selective inhibition for Ral relative to Ras or Rho and inhibit xenograft tumor growth.
|
T40286 |
KRAS G12C inhibitor 19
|
2649788-46-3
|
98.31%
|
|
KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth.
|
T3553 |
Y16
|
429653-73-6
|
98.26%
|
|
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated sign...
|
T2700 |
FTI-277 hydrochloride
|
180977-34-8
|
98.19%
|
|
FTI-277 hydrochloride (FTI 277 HCl) is an effective and specific farnesyltransferase (FTase) inhibitor (IC50: 500 pM); this selectivity is about 100-fold than th...
|
T8473 |
MLS000532223
|
16616-39-0
|
98.11%
|
|
MLS000532223 is a selectiveRho family GTPases inhibitor(EC50 : 16 μM to 120 μM).
|
T16021 |
MBQ-167
|
2097938-73-1
|
98.07%
|
|
MBQ-167 is a dual inhibitor of Rac/Cdc42 (IC50s: 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively).
|
T7609 |
ARS-1620
|
1698055-85-4
|
98%
|
|
ARS-1620 is a covalent inhibitor of K-RASG12C.
|
T1876 |
Kobe0065
|
436133-68-5
|
98%
|
|
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H...
|
T7131 |
Antineoplaston A10
|
91531-30-5
|
98%
|
|
Antineoplaston A10 (NSC-648539) is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer.
|
T22249 |
1588-A4
|
1698027-20-1
|
98%
|
|
1588-A4 (ARS-1620 Intermediate) is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
|
T6302 |
Lonafarnib
|
193275-84-2
|
98%
|
|
Lonafarnib (Sch66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B, and N-ras (IC50: 1.9/5.2/2.8 nM).
|
T7326 |
6H05 (TFA)
|
2061344-88-3
|
98%
|
|
6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.
|
T7558 |
CID-1067700
|
314042-01-8
|
98%
|
|
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases(Rab7 with a Ki of 13 nM).
|
T5597 |
ZT-12-037-01
|
2328073-61-4
|
98%
|
|
Zt-12-037-01 is a ATP competitive STK19 inhibitor(IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).
|